About this trial
Pelvic congestion syndrome (PCS) is a common cause of chronic pelvic pain in women and is associated with pelvic venous insufficiency. This prospective interventional study aims to evaluate the safety and clinical effectiveness of endovascular embolization in relieving symptoms and improving quality of life in women diagnosed with PCS
Eligibility criteria
Qualifiers
Female patients aged 18 years or older.
Chronic pelvic pain for more than 6 months.
Clinical suspicion of pelvic congestion syndrome.
Imaging findings consistent with pelvic congestion syndrome on Doppler ultrasound, CT venography, MR venography, or catheter venography.
Disqualifiers
Pregnancy.
Active pelvic inflammatory disease.
Known pelvic malignancy.
Chronic pelvic pain due to other identifiable causes (e.g., endometriosis, large uterine fibroids).
Trial design
Treatments tested in this trial
- Endovascular embolization